TBPH — Theravance Biopharma Share News
0.000.00%
Last trade - 00:00- $883.66m
- $528.80m
- $107.46m
Brief: Theravance Biopharma, Inc. Reports First Quarter 2023 Financial Results
Theravance Biopharma Inc reports results for the quarter ended in March - Earnings Summary
Theravance Biopharma Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Weiss Asset Management Reports 11.79% Stake In Theravance Biopharma
Brief: Theravance Biopharma, Inc. Announces Appointment Of Jim Kelly, Managing Director At Weiss Asset Management, To Board Of Directors
Brief: Theravance Biopharma Says Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank
Brief: Theravance Biopharma, Inc. Announces Strategic Actions And Reports Fourth Quarter / Full Year 2022 Financial Results And Business Update
Theravance Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Irenic Capital urges Theravance to conduct review, add shareholder to board (updated)
Brief: Irenic Sends Letter To Theravance Biopharma Regarding The Urgent Need For A Governance Overhaul, Capital Return And Strategic Review
Irenic Capital urges Theravance to conduct review, add shareholder to board
Theravance Biopharma Inc expected to post a loss of 17 cents a share - Earnings Preview
Theravance Biopharma Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Theravance Biopharma Expects To Complete Pifr-2 Study And Provide Top-Line Results In 2H 2023
Brief: Theravance Biopharma CFO Andrew Hindman Steps Down
Brief: Theravance Biopharma Announces Preliminary Results Of Tender Offer
Theravance Biopharma Inc reports results for the quarter ended in September - Earnings Summary
Brief: Theravance Biopharma Inc Reports Third Quarter 2022 Financial Results
Theravance Biopharma Inc expected to post a loss of 18 cents a share - Earnings Preview